
AACR Virtual Annual Meeting II: Opening Plenary Captures the Breadth of Cutting-edge Cancer Research
Following the resounding success of the First Virtual Annual Meeting with more than 61,000 attendees in April, the AACR...
Home »
Following the resounding success of the First Virtual Annual Meeting with more than 61,000 attendees in April, the AACR...
The days are getting longer and warmer, and visions of beach trips, cookouts, and picnics occupy our minds. While this year’s summer will likely look different due to the ongoing COVID-19 pandemic, months...
Signaling pathways that regulate cellular proliferation are commonly mutated in cancer cells, leading to unrestrained cellular division and tumor growth. Therefore, insight into the...
The unrestrained cellular proliferation that characterizes cancer largely arises due to genetic mutations, which can impede the regulatory mechanisms that control when and how often a cell divides. Genetic mutations may also...
Clinical trials were a major focus of the AACR Virtual Annual Meeting I, spanning nine plenary sessions over the two-day...
Over the course of the two-day AACR Virtual Annual Meeting I, more than 61,000 people from 140 countries around the...
Over the past decade, immune checkpoint inhibitors have transformed cancer care for a variety of tumor types. This form of immunotherapy can lead to long-lasting...
At the time of this writing, more than 3.3 million individuals have been diagnosed with COVID-19, and more than 222,000 have died from the...
A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
Early detection of most cancers is an elusive and daunting task; nevertheless, it has remained a top priority for...